|
Gustavo Turecki, MD, PhD (born May 11, 1965) is an award-winning Canadian psychiatrist and professor at McGill University. He is a William Dawson Scholar and Chair of the Department of Psychiatry,〔(【引用サイトリンク】title=Research | Department of Psychiatry - McGill University )〕 and works at the Douglas Mental Health University Institute, where he heads both the McGill Group for Suicide Studies〔(【引用サイトリンク】title=McGill Group for Suicide Studies )〕 and the Depressive Disorders Program. He is also the director of the FRQS Quebec Network on Suicide, Mood Disorders and Related Disorders,〔(【引用サイトリンク】title=Quebec Network on Suicide, Mood Disorders and Related Disorders RQSHA )〕 and the co-director of the Douglas Bell-Canada Brain Bank.〔(【引用サイトリンク】title=The Brain Bank | The Douglas Bell Canada Brain Bank )〕 As a clinician and neuroscientist, his research focuses on examining the influence of life experiences on brain function, and their relationship to depression and suicide risk. Among his major contributions, published in more than 300 peer-reviewed publications and book chapters,〔(【引用サイトリンク】title=g turecki[Author] - PubMed - NCBI )〕 is the first description of the long-term impact of childhood abuse on the brain, particularly how it affects the activity of key genes involved in stress-response. == Personal history == Turecki was born in La Plata, Buenos Aires, Argentina on May 11, 1965. He is married and has three children. He trained in medicine at the UNIFESP (Federal University of São Paulo|Universidad Federal de São Paulo), in Brazil, and further specialized in psychiatry, completing his residency in 1994. He then moved to Montreal, Canada, to pursue a PhD in Neuroscience at McGill University (Montréal, QC), where he studied molecular genetics under the supervision of Dr. Guy Rouleau. After completing his PhD in 1999, Turecki established himself both as a clinician, at the Douglas Mental Health University Institute, and as a researcher. He is currently a Full Professor in the Departments of Psychiatry and Human Genetics at McGill University. His research focuses on molecular changes taking place in the brain of depressed individuals and on suicide risk. Turecki continues to be active as a clinician at the Douglas Mental Health University Institute, where he heads the Depressive Disorders Program, a third-line clinical program focused on treating patients with major depressive disorder. His dual role as a researcher and a clinician has allowed him to bridge the gap between basic neuroscience research and clinical work, and continues to add strength to his research programs. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Gustavo Turecki」の詳細全文を読む スポンサード リンク
|